Updated guidelines for managing psoriatic arthritis

The European Alliance of Associations for Rheumatology’s updated recommendations on the management of psoriatic arthritis may provide a more comprehensive, personalized approach to treating the disease — while incorporating pharmacologic advances and tailoring treatment strategies based on patient needs and disease manifestations. The updated guidelines were published in the Annals of the Rheumatic Diseases.

Through a review process, an international team of researchers developed evidence- and consensus-based methodologies to optimize treatment approaches. Among the key updates were seven overarching principles and 11 detailed recommendations covering individualized treatments; shared decision-making; comprehensive care addressing comorbidities; regular assessments using validated outcome measures; early interventions; the use of nonsteroidal anti-inflammatory drugs, oral glucocorticoids and conventional synthetic disease-modifying antirheumatic drugs and tailoring treatment strategies on the basis of clinical manifestations and comorbidities.

The researchers hope the updated guidelines provide a framework for the personalized, evidence-based management of psoriatic arthritis.

Read more: Annals of the Rheumatic Diseases

The article presented here is intended to inform you about the broader media perspective on dentistry, regardless of its alignment with the ADA's stance. It is important to note that publication of an article does not imply the ADA's endorsement, agreement, or promotion of its content.